Where does 10x Genomics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), 10x Genomics, Inc. ranks #1,132 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does 10x Genomics, Inc. hold?

10x Genomics, Inc. holds 373 US utility patents granted between 2016 and 2025, spanning 35 technology areas.

What is 10x Genomics, Inc.'s Innovation Score?

10x Genomics, Inc. has an Innovation Score of 68.9 out of 100 (top 1% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is 10x Genomics, Inc.'s patent grant rate increasing or decreasing?

10x Genomics, Inc.'s recent grant velocity is +329% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for 10x Genomics, Inc.'s patents?

10x Genomics, Inc.'s patents average 26.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the 10x Genomics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

10x Genomics, Inc.

Q: What technology areas does 10x Genomics, Inc. focus on?

10x Genomics, Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 282 patents, ranking #6 of 2,502 assignees active in that subclass. Grants appear in 35 CPC subclasses total.

USPTO PatentsView assignee record - 373 granted patents across 35 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, 10x ranks #1,132 of 49,997 tracked US assignees by granted-patent volume, with 373 patents across 35 technology areas.

#1,132
of 49,997 US assignees by volume: Top 1%
by Innovation Score (68.9/100): 26.5
avg claims per patent: +329%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1132 · US Corporation #1,132 · 373 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-STRONG · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MID 373 grants
TOP-DECILE #1,132/49,997
PHOTO-FINISH Huawei Digital Power
CPC-FOCUS C12Q · 35 areas
INNOV-STRONG 68.9/100
CLAIMS-DENSE 26.5 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +329% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Huawei Digital Power Technologies Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How 10x’s 68.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 20.5 pts (30%) Velocity 12.5 pts (18%) Breadth 20.9 pts (30%) Claim depth 15.0 pts (22%)

Qualcomm Incorporated · highest

85
10x Genomics · this assignee

69
Festool · near

69
Angel · near

69
Vestas Wind Systems… · near

69
Zhejiang Geely… · near

69
3D Lighting… · lowest

7

What this shows 10x's Innovation Score is 68.9/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for 10x?

Each dot is one of 10x’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). 10x’s own 26.5 claims/patent is ABOVE the 17.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

10x vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where 10x's grants concentrate

10x Genomics, Inc. is a focused PatentsView assignee: 35 CPC subclasses with 75.6% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2024 (82 grants) versus a trough of 4 in 2016. By volume, 10x sits between Mercedes-Benz Group AG and Samsung SDS Co., Ltd..

10x's three-year grant acceleration

From 2019–2021 to 2022–2024, 10x Genomics, Inc. moved from 92 to 173 grants (1.88x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #246. See the growth leaderboard.

Mercedes-benz Gro…

375
TE Connectivity G…

375
Anthura B V

374
Mako Surgical

374
Huawei Digital Po…

373
Nokia

373
University of Bri…

373
10x Genomics ◀

373
Samsung SDS

372

What this shows 10x holds 373 patents at rank #1,132, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near 10x

By rank, the assignees closest to #1,132 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in 10x's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for 10x, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), 10x ranks #6 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (69 here).

Festool GMBH 69 Angel Co., Ltd. 69 Vestas Wind Systems A/S 69 Zhejiang Geely Holding Group Co., Ltd. 69

Similar claim depth

Nearest assignees by average claims per patent (26.5 here).

Prognosys Biosciences, Inc. 26.5 avg Beijing Research Institute OF Chemical Industry, China Petroleum & Chemical Corporation 26.5 avg iCometrue Company Ltd. 26.4 avg Nokomis, Inc. 26.6 avg

10x's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

69 Top 1% higher than 99% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

10x Genomics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	4	1.1%
2017	7	1.9%
2018	15	4.0%
2019	29	7.8%
2020	41	11.0%
2021	22	5.9%
2022	29	7.8%
2023	62	16.6%
2024	82	22.0%
2025partial year	82	22.0%

Which technologies does 10x Genomics, Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 282

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 137

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 89

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 59

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 37

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 37

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 21

G06F - Electric Digital Data Processing 19

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 17

C07K - Peptides 15

G06T - Image Data Processing OR Generation, IN General 12

C12Y - Enzymes 12

G02B - Optical Elements, Systems OR Apparatus 9

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 9

G06V - Image OR Video Recognition OR Understanding 9

Top 15 of 35 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

10x Genomics, Inc.'s patent record in context - here's where to go next.

10x Genomics, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 75.6% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #1,132 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare 10x Genomics, Inc. against Mercedes-Benz Group AG, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 68.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.